Latest Post

April 19, 2021

NovaPure® Components Answer Your Concerns over Particulates in Biologics

An enormous growth trend is being observed in the market for biologic drugs; they are being employed ever more frequently as treatments for chronic issues such as cancer and autoimmune diseases. This growth is reflected by the number of companies involved (established and emerging), and in the capital investment for manufacturing facilities for both biologics and biosimilars. Companies must apply a holistic approach to bringing a biologic drug to market. 
Qian Liu

Nancy Liu

Sr. Specialist, TCS, China

Previous Posts
NovaGuard SA Pro Safety System

March 22, 2021

Prevention of Needlestick Injuries with Safety Systems

Katalin Halbrucker

Katalin Halbrucker

Technical Account Specialist, TCS, EU

FluroTec Barrier Film

February 02, 2021

Why FluroTec® Barrier Film for Lyophilization Stoppers

Deolinda Martins

Deolinda Martins

Manager, Technical Accounts, TCS

Prefilled Glass Syringes with NovaPure plungers

January 25, 2021

Benefits of Prefilled Syringes

Mary Tan

Mary Tan

Specialist, Scientific Affairs, Singapore

Daikyo D Sigma Pistons

August 21, 2020

Daikyo D Sigma® 1mL Long Pistons – Performance Excellence

Katie Espenshade

Katie Espenshade

Sr. Technical Account Manager, TCS, NA

Daikyo D Sigma Pistons

July 20, 2020

High Quality Solution and Innovation Excellence with Daikyo D Sigma® Elastomer Components for PFS

Christa Jansen-Otten

Christa Jansen-Otten

Director, Global Product Management, PFS & Delivery

AccelTRA Components Program

June 26, 2020

Performance of AccelTRA® Components

Qian Liu

Nancy Liu

Senior Specialist, TCS, China

Load more